Not all patients are able to reap the benefits of groundbreaking new therapeutics. The industry must do more.

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Scientists develop treatment that leads to complete regression of breast tumors in mice.

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Why you shouldn’t neglect the importance of blending people, culture, and strategy to foster success in a business.

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

US-based pharmaceutical associations fear the supply chain repercussions of tariffs, and offer advice for a more sustainable alternative.